Executive Summary
The analytical procedure lifecycle is a modern, holistic framework (USP ⟨1220⟩) for design, qualification, and ongoing verification of analytical methods. Rather than treating a method as “validated once,” it treats it as a managed process that must remain fit for purpose over its entire lifespan. This lifecycle approach aligns with Quality by Design (QbD) and current ICH expectations (Q14 for development; Q2(R2) for validation).
Stage 1 — Procedure Design & Development
Define the Analytical Target Profile (ATP) and build quality in from the start through scientific understanding and risk management. Typical activities include identifying performance criteria, assessing risks/critical method parameters, and (where appropriate) using tools like DoE to establish ranges and a method control strategy.
Stage 2 — Analytical Procedure Performance Qualification (APPQ)
Formally demonstrate the procedure, as designed, is suitable for its intended purpose. Activities commonly include validation per ICH Q2(R2) (e.g., specificity/selectivity, accuracy, precision, range, detection/quantitation limits, robustness as appropriate), and may also include verification and method transfer when applicable. Outputs include a protocol and a validation report. Partial or full re-validation may be needed after lifecycle changes.
Stage 3 — Ongoing/Continued Procedure Performance Verification (OPPV)
During routine use, maintain a state of control by risk-based monitoring of performance data (e.g., SST trends and/or reportable results), employing control charts and predefined indicators to detect drift and trigger action. This provides ongoing evidence the method continues to meet its ATP and supports controlled change management.
Regulatory anchors: USP ⟨1220⟩ defines the three-stage lifecycle; ICH Q14 embeds ATP-driven development and lifecycle management; ICH Q2(R2) provides the validation framework and explicitly situates validation within the lifecycle.